Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial of Favipiravir and Hydroxychloroquine Combination in Adults Hospitalized With Moderate and Severe Covid-19

NCT04392973 is registered in ClinicalTrials.gov with King Abdullah International Medical Research Center as lead sponsor.

NCT NCT04392973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04392973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial of Favipiravir and Hydroxychloroquine Combination in Adults Hospitalized With Moderate and Severe Covid-19
Lead sponsor
King Abdullah International Medical Research Center
Phase
Not applicable
Overall status
Completed
Start date
May 21, 2020
Completion date
April 26, 2021
Enrollment
268 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid19